AADI
Price:
$1.83
Market Cap:
$45.05M
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.[Read more]
Industry
Biotechnology
IPO Date
2018-02-16
Stock Exchange
NASDAQ
Ticker
AADI
According to Aadi Bioscience, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.75. This represents a change of -30.98% compared to the average of -1.09 of the last 4 quarters.
The mean historical PE Ratio of Aadi Bioscience, Inc. over the last ten years is -569.81. The current -0.75 PE Ratio has changed -86.84% with respect to the historical average. Over the past ten years (40 quarters), AADI's PE Ratio was at its highest in in the September 2018 quarter at 2.96. The PE Ratio was at its lowest in in the March 2015 quarter at -6982.81.
Average
-569.81
Median
-4.94
Minimum
-5659.04
Maximum
-0.72
Discovering the peaks and valleys of Aadi Bioscience, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 173.25%
Maximum Annual PE Ratio = -0.72
Minimum Annual Increase = -99.83%
Minimum Annual PE Ratio = -5659.04
Year | PE Ratio | Change |
---|---|---|
2023 | -0.83 | -83.68% |
2022 | -5.07 | 158.81% |
2021 | -1.96 | 173.25% |
2020 | -0.72 | -34.18% |
2019 | -1.09 | -80.38% |
2018 | -5.55 | 15.33% |
2017 | -4.81 | -49.66% |
2016 | -9.56 | 0.51% |
2015 | -9.51 | -99.83% |
2014 | -5659.04 | -4.65% |
The current PE Ratio of Aadi Bioscience, Inc. (AADI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.62
5-year avg
-1.93
10-year avg
-569.81
Aadi Bioscience, Inc.’s PE Ratio is greater than Anebulo Pharmaceuticals, Inc. (-4.99), greater than Adagene Inc. (-2.86), greater than Acrivon Therapeutics, Inc. Common Stock (-4.23), greater than AnaptysBio, Inc. (-5.77), greater than Mineralys Therapeutics, Inc. (-4.63), less than AN2 Therapeutics, Inc. (-0.47), less than Aerovate Therapeutics, Inc. (-0.62), greater than Gracell Biotechnologies Inc. (-12.26), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than Monte Rosa Therapeutics, Inc. (-3.11), greater than Design Therapeutics, Inc. (-5.23), greater than Erasca, Inc. (-3.94), greater than Rezolute, Inc. (-3.80), greater than Ultragenyx Pharmaceutical Inc. (-8.17), greater than Crinetics Pharmaceuticals, Inc. (-15.40), greater than Arvinas, Inc. (-5.42), greater than Revolution Medicines, Inc. (-13.31), greater than Kura Oncology, Inc. (-9.19),
Company | PE Ratio | Market cap |
---|---|---|
-4.99 | $46.68M | |
-2.86 | $115.55M | |
-4.23 | $250.26M | |
-5.77 | $1.08B | |
-4.63 | $558.43M | |
-0.47 | $30.44M | |
-0.62 | $54.85M | |
-12.26 | $989.87M | |
-3.19 | $181.50M | |
-3.11 | $349.21M | |
-5.23 | $264.42M | |
-3.94 | $807.96M | |
-3.80 | $240.80M | |
-8.17 | $5.09B | |
-15.40 | $4.03B | |
-5.42 | $1.68B | |
-13.31 | $6.99B | |
-9.19 | $1.48B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aadi Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aadi Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aadi Bioscience, Inc.'s PE Ratio?
How is the PE Ratio calculated for Aadi Bioscience, Inc. (AADI)?
What is the highest PE Ratio for Aadi Bioscience, Inc. (AADI)?
What is the 3-year average PE Ratio for Aadi Bioscience, Inc. (AADI)?
What is the 5-year average PE Ratio for Aadi Bioscience, Inc. (AADI)?
How does the current PE Ratio for Aadi Bioscience, Inc. (AADI) compare to its historical average?